News tagged with hiv virus
A new optical microscopy approach opens the door to better observations in molecular biology
Researchers from the Institut Pasteur and CNRS have set up a new optical microscopy approach that combines two recent imaging techniques in order to visualize molecular assemblies without affecting their biological ...
May 17, 2012 |
not rated yet |
0
Unpicking HIV’s invisibility cloak
Drug researchers hunting for alternative ways to treat human immunodeficiency virus (HIV) infections may soon have a novel targetits camouflage coat. HIV hides inside a cloak unusually rich in a sugar ...
Feb 10, 2012 |
5 / 5 (6) |
0
Plasma-based treatment goes viral
Life-threatening viruses such as HIV, SARS, hepatitis and influenza, could soon be combatted in an unusual manner as researchers have demonstrated the effectiveness of plasma for inactivating and preventing ...
Dec 05, 2011 |
4.3 / 5 (8) |
2
|
Potential new drugs plug brain's biological 'vacuum cleaner' and target HIV
In an advance toward eliminating pockets of infection in the brain that help make HIV disease incurable, scientists report the development of new substances that first plug the biological vacuum cleaner that ...
Oct 12, 2011 |
3 / 5 (1) |
0
Tests underway for new HIV drug farmed from GM tobacco plants
A clinical trial of a potential Human Immunodeficiency Virus (HIV) drug farmed from genetically modified (GM) tobacco plants has at long last got underway in the United Kingdom. The beginning of the trial ...
Aug 25, 2011 |
not rated yet |
0
Scientists uncover new factor in HIV infection
A George Mason University researcher team has revealed the specific process by which the HIV virus infects healthy T cellsa process previously unknown. The principal investigator, HIV researcher Yuntao Wu, says he hopes ...
Aug 24, 2011 |
5 / 5 (2) |
0
|
Entry prohibited for AIDS viruses: Peptide triazole inhibitors disrupt cell-free HIV-1
(PhysOrg.com) -- The initial entry of HIV-1 into host cells remains a compelling yet elusive target for the development of agents to prevent infection, a critical need in the fight against the global AIDS ...
Jul 08, 2011 |
not rated yet |
1
S.Africa nearly wipes out infant AIDS infections: study
South Africa's programme to prevent HIV in babies has achieved a 96.5 percent success rate in wiping out transmission from infected pregnant mothers, the Medical Research Council said Thursday.
Medicine & Health / HIV & AIDS
Jun 09, 2011 |
2 / 5 (1) |
2
Longevity of AIDS patients presents new risks: US
Thirty years after the AIDS epidemic first surfaced, more people than ever before in the United States -- more than 1.1 million -- are living with HIV, the Centers for Disease Control said Thursday.
Medicine & Health / HIV & AIDS
Jun 02, 2011 |
not rated yet |
0
The 30 Years War: AIDS, a tale of tragedy and hope
On June 5 1981, American epidemiologists reported a baffling event: five young gay men in Los Angeles, all previously healthy, had fallen ill with pneumonia. Two had died.
Medicine & Health / HIV & AIDS
May 29, 2011 |
not rated yet |
3
Some monkeys born with gene that protects against AIDS
A certain gene in some monkeys can help boost vaccine protection against simian immunodeficiency virus (SIV), a trait that could help researchers develop better AIDS vaccines for humans, suggested a study ...
Medicine & Health / HIV & AIDS
May 04, 2011 |
4 / 5 (2) |
0
AIDS prevention pill study halted; no benefit seen
Researchers are stopping a study that tests a daily pill to prevent infection with the AIDS virus in thousands of African women because partial results show no signs that the drug is doing any good.
Medicine & Health / HIV & AIDS
Apr 18, 2011 |
not rated yet |
0
HIV-1 drug resistance mutations associated with increased risk of antiretroviral treatment failure
An analysis of data from 10 studies indicates that the presence of low frequency (also called "minority") human immunodeficiency virus type 1 (HIV-1) drug resistance mutations, particularly those involving nonnucleoside reverse ...
Medicine & Health / HIV & AIDS
Apr 05, 2011 |
not rated yet |
0
Study identifies promising target for AIDS vaccine
A section of the AIDS virus's protein envelope once considered an improbable target for a vaccine now appears to be one of the most promising, new research by Dana-Farber Cancer Institute scientists indicates.
Medicine & Health / HIV & AIDS
Mar 31, 2011 |
5 / 5 (1) |
0
After 30 years, war on AIDS at 'moment of truth'
With the war on AIDS nearing its 30th anniversary, the UN on Thursday declared "a moment of truth" had come for new strategies to address the campaign's failures and brake costs that were now unsustainable.
Medicine & Health / HIV & AIDS
Mar 31, 2011 |
not rated yet |
0
HIV
Human immunodeficiency virus (HIV) is a lentivirus (a member of the retrovirus family) that causes acquired immunodeficiency syndrome (AIDS), a condition in humans in which the immune system begins to fail, leading to life-threatening opportunistic infections. Infection with HIV occurs by the transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells. The four major routes of transmission are unsafe sex, contaminated needles, breast milk, and transmission from an infected mother to her baby at birth (Vertical transmission). Screening of blood products for HIV has largely eliminated transmission through blood transfusions or infected blood products in the developed world.
HIV infection in humans is now pandemic. From 1981 to 2006, AIDS killed more than 25 million people. HIV infects about 0.6 percent of the world's population. In 2005 alone, AIDS claimed an estimated 2.4–3.3 million lives, of which more than 570,000 were children. A third of these deaths are occurring in sub-Saharan Africa, retarding economic growth and increasing poverty. According to current estimates, HIV is set to infect 90 million people in Africa, resulting in a minimum estimate of 18 million orphans. Antiretroviral treatment reduces both the mortality and the morbidity of HIV infection, but routine access to antiretroviral medication is not available in all countries.
HIV primarily infects vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages, and dendritic cells. HIV infection leads to low levels of CD4+ T cells through three main mechanisms: firstly, direct viral killing of infected cells; secondly, increased rates of apoptosis in infected cells; and thirdly, killing of infected CD4+ T cells by CD8 cytotoxic lymphocytes that recognize infected cells. When CD4+ T cell numbers decline below a critical level, cell-mediated immunity is lost, and the body becomes progressively more susceptible to opportunistic infections.
Eventually most HIV-infected individuals develop AIDS. These individuals mostly die from opportunistic infections or malignancies associated with the progressive failure of the immune system. Without treatment, about 9 out of every 10 persons with HIV will progress to AIDS after 10–15 years. Many progress much sooner. Treatment with anti-retrovirals increases the life expectancy of people infected with HIV. Even after HIV has progressed to diagnosable AIDS, the average survival time with antiretroviral therapy (as of 2005) is estimated to be more than 5 years. Without antiretroviral therapy, death normally occurs within a year.
For more information about HIV, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.